ATE407664T1 - Hydrogel zusammensetzungen, geeignet zur verzögerten freisetzung von makromolekülen sowie verfahren zur herstellung derselben. - Google Patents

Hydrogel zusammensetzungen, geeignet zur verzögerten freisetzung von makromolekülen sowie verfahren zur herstellung derselben.

Info

Publication number
ATE407664T1
ATE407664T1 AT00904513T AT00904513T ATE407664T1 AT E407664 T1 ATE407664 T1 AT E407664T1 AT 00904513 T AT00904513 T AT 00904513T AT 00904513 T AT00904513 T AT 00904513T AT E407664 T1 ATE407664 T1 AT E407664T1
Authority
AT
Austria
Prior art keywords
macromolecles
production
same
delayed release
compositions suitable
Prior art date
Application number
AT00904513T
Other languages
English (en)
Inventor
Petr Kuzma
Harry Quandt
Original Assignee
Indevus Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indevus Pharmaceuticals Inc filed Critical Indevus Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE407664T1 publication Critical patent/ATE407664T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polymerisation Methods In General (AREA)
  • Steroid Compounds (AREA)
AT00904513T 1999-01-28 2000-01-26 Hydrogel zusammensetzungen, geeignet zur verzögerten freisetzung von makromolekülen sowie verfahren zur herstellung derselben. ATE407664T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11754699P 1999-01-28 1999-01-28

Publications (1)

Publication Number Publication Date
ATE407664T1 true ATE407664T1 (de) 2008-09-15

Family

ID=22373509

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00904513T ATE407664T1 (de) 1999-01-28 2000-01-26 Hydrogel zusammensetzungen, geeignet zur verzögerten freisetzung von makromolekülen sowie verfahren zur herstellung derselben.

Country Status (11)

Country Link
US (1) US6361797B1 (de)
EP (1) EP1067911B1 (de)
JP (1) JP2002535452A (de)
AT (1) ATE407664T1 (de)
AU (1) AU757605B2 (de)
CA (1) CA2325386C (de)
DE (1) DE60040190D1 (de)
DK (1) DK1067911T3 (de)
ES (1) ES2313879T3 (de)
PT (1) PT1067911E (de)
WO (1) WO2000044356A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
DE10049297A1 (de) * 2000-10-04 2002-04-11 Basf Ag Wasserlösliche oder wasserdispergierbare (Co-)Polymerisate von Hydroxyalkyl(meth)acrylaten, Verfahren zu deren Herstellung sowie deren Verwendung als Überzugs-, Bindemittel und/oder filmbildender Hilfsstoff in pharmazeutischen Darreichungsformen
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
JP2005526879A (ja) * 2002-03-11 2005-09-08 ファースト ウォーター リミテッド 吸収性ハイドロゲル
US20060127878A1 (en) * 2002-12-18 2006-06-15 Salomon David H Hydrogel preparation and process of manufacture thereof
US20040214914A1 (en) * 2003-04-24 2004-10-28 Ocular Sciences, Inc. Hydrogel contact lenses and package systems and production methods for same
WO2006009801A2 (en) 2004-06-17 2006-01-26 Valera Pharmaceuticals, Inc. Compositions and methods for treating central precocious puberty
CA2581896C (en) 2004-09-29 2015-11-10 Mount Sinai School Of Medicine Of New York University Fsh and fsh receptor modulator compositions and methods for inhibiting osteoclastic bone resorption and bone loss in osteoporosis
US7759312B2 (en) * 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
NZ561400A (en) * 2005-03-11 2010-02-26 Endo Pharmaceuticals Solutions Controlled release formulations of octreotide
NZ543314A (en) * 2005-10-28 2007-08-31 Interag A delivery system where the driving substance contains the active component
BRPI0810606B1 (pt) * 2007-04-27 2018-10-16 Endo Pharmaceuticals Solutions dispositivo de implante e processo para sua preparação
US8222015B2 (en) * 2007-05-11 2012-07-17 Toyota Motor Engineering & Manufacturing North America, Inc. Heat resistant bioactive composition
WO2009029958A2 (en) * 2007-08-30 2009-03-05 Sunstorm Research Corporation Implantable delivery device
WO2009158412A2 (en) 2008-06-25 2009-12-30 Endo Pharmaceuticals Solutions Inc. Sustained delivery of exenatide and other polypeptides
UA104866C2 (uk) * 2008-06-25 2014-03-25 Ендо Фармас'Ютікалз Солюшнз Інк. Імплантат октреотиду, який містить вивільняючу речовину
WO2011057131A1 (en) 2009-11-09 2011-05-12 Spotlight Technology Partners Llc Polysaccharide based hydrogels
CA2780274C (en) 2009-11-09 2018-06-26 Spotlight Technology Partners Llc Fragmented hydrogels
US8329219B2 (en) 2009-12-22 2012-12-11 Cook Biotech Incorporated Methods for producing ECM-based biomaterials
CN104822366B (zh) * 2012-07-13 2018-03-06 塔夫茨大学 在丝纤蛋白生物材料中香料和/或调味剂的包封
US11413329B2 (en) 2012-10-20 2022-08-16 Board Of Regents, The University Of Texas System Cancer cell trap
WO2015143295A2 (en) 2014-03-20 2015-09-24 The Regents Of The University Of California Hydrogel compositions containing toxin-absorbing or binding nanoparticles and uses thereof
WO2019117976A1 (en) 2017-12-17 2019-06-20 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Peptide hydrogels and use thereof
EP3791864A1 (de) 2019-09-13 2021-03-17 UPM-Kymmene Corporation Verfahren zur herstellung einer pharmazeutischen zusammensetzung sowie pharmazeutische zusammensetzung
EP3791858A1 (de) * 2019-09-13 2021-03-17 UPM-Kymmene Corporation Injizierbare pharmazeutische formulierung

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298002A (en) * 1979-09-10 1981-11-03 National Patent Development Corporation Porous hydrophilic materials, chambers therefrom, and devices comprising such chambers and biologically active tissue and methods of preparation
US4959217A (en) * 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
AU618817B2 (en) * 1988-07-05 1992-01-09 Novartis Ag Dimethylacrylamide-copolymer hydrogels with high oxygen permeability
US4954587A (en) 1988-07-05 1990-09-04 Ciba-Geigy Corporation Dimethylacrylamide-copolymer hydrogels with high oxygen permeability
ATE106015T1 (de) 1990-09-28 1994-06-15 Pfizer Wirkstoffabgabevorrichtung die ein hydrophobisches mittel enthält.
US5266325A (en) * 1990-09-28 1993-11-30 Hydro Med Science Division Of National Patent Development Corp. Preparation of homogeneous hydrogel copolymers
AU651654B2 (en) * 1992-01-14 1994-07-28 Endo Pharmaceuticals Solutions Inc. Manufacture of water-swellable hydrophilic articles and drug delivery devices
JPH04202201A (ja) * 1990-11-29 1992-07-23 Mitsui Toatsu Chem Inc 多孔性共重合体の製造方法
JP2530079B2 (ja) * 1992-02-05 1996-09-04 ナショナル・パテント・ディベロプメント・コーポレーション 水分膨潤性親水性製品及び薬物放出装置の製造

Also Published As

Publication number Publication date
EP1067911B1 (de) 2008-09-10
PT1067911E (pt) 2008-12-22
DK1067911T3 (da) 2009-01-26
DE60040190D1 (de) 2008-10-23
WO2000044356A9 (en) 2001-07-26
AU757605B2 (en) 2003-02-27
CA2325386A1 (en) 2000-08-03
EP1067911A4 (de) 2003-05-21
WO2000044356A1 (en) 2000-08-03
CA2325386C (en) 2010-03-23
US6361797B1 (en) 2002-03-26
JP2002535452A (ja) 2002-10-22
EP1067911A1 (de) 2001-01-17
ES2313879T3 (es) 2009-03-16
AU2625600A (en) 2000-08-18

Similar Documents

Publication Publication Date Title
DE60040190D1 (de) Hydrogel zusammensetzungen, geeignet zur verzögerten freisetzung von makromolekülen sowie verfahren zur herstellung derselben.
DE602004030821D1 (de) Poröse verbundmaterialien sowie verfahren zur herstellung und verwendung davon
DE60011243D1 (de) Verfahren zur herstellung von mit antioxidant gedoptem uhmwpe und daraus hergestelltes implantat
DE60323340D1 (de) Verfahren zur herstellung interferierender rna-moleküle in säugetierzellen und therapeutische anwendungen solcher moleküle
ATE487746T1 (de) Geträgerter hybridmetallocenkatalysator, herstellungsverfahren dafür und verfahren zur herstellung von polyolefinen damit
ATE292959T1 (de) Verfahren zur herstellung von pankreasenzym enthaltende mikrosphären mit hoher stabilität
ATE389678T1 (de) Verfahren zur herstellung von wässrigen dispersionen
ATE464373T1 (de) Zelluläre zusammensetzungen und verfahren zur deren bereitung und verwendung
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
ATE224927T1 (de) Filamentöse, poröse filme und verfahren zu ihrer herstellung
ATE430160T1 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
ATE372336T1 (de) Prozess zur herstellung von pioglitazon via verschiedene zwischenstufen
DE60014123D1 (de) Verfahren zur herstellung von porösen polymerpellets
ATE461226T1 (de) Verfahren zur herstellung von polyacrolein
ATE537173T1 (de) Verfahren zur herstellung von cucurbiturilen
DE50105968D1 (de) VERFAHREN ZUR HERSTELLUNG VON AlKYLVERBRÜCKTEN LIGANDSYSTEMEN UND ÜBERGANGSMETALLVERBINDUNGEN
ATE369122T1 (de) Verfahren zur herstellung von implantaten mittels lösungsmittelfreier herstellung eines homogenisats
DE59909917D1 (de) Diphenyl-substituierte 5-ring-heterocyclen, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
ATE476426T1 (de) Verfahren zur herstellung von alkoxycarbonylamino-triazinen
DE602005009978D1 (de) Verfahren zur herstellung von zwei- und dreidimensionalen polymergerüsten
DE602004003037D1 (de) Verfahren und zwischenprodukte für die herstellung von emtricitabin
DE60006111D1 (de) Aluminosiloxanverbindungen und verfahren zu ihrer herstellung
ATE440605T1 (de) Verfahren zur herstellung von camptothecin- derivaten
DE502004010100D1 (de) Verfahren zur Herstellung von 9,10-Dihydro-9-oxa-10-organyl-oxyphosphaphenanthren-10-oxid oder -thion und an den Phenylgruppen substituierten Derivativen desselben
ATE374755T1 (de) Verfahren zur herstellung von 1,3,5- triazincarbamaten und -harnstoffen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1067911

Country of ref document: EP

REN Ceased due to non-payment of the annual fee